Income Taxes (Tables)

12 Months Ended

Dec. 31, 2018

Income Tax Disclosure [Abstract]

Schedule of Deferred Tax Assets

Significant components of the Company’s deferred tax assets as of December 31, 2018 and 2017 are summarized below.

	December 31,
	2018			2017
Capitalized research and development costs	$	183,000		$	183,000
Research and development credits		3,017,000			3,017,000
Stock-based compensation		3,787,000			3,628,000
Stock options issued in connection with the payment of debt		202,000			199,000
Net operating loss carryforwards		20,424,000			25,569,000
Accrued compensation		367,000			135,000
Accrued interest due to related party		103,000			83,000
Other, net		8,000			10,000
Total deferred tax assets		28,091,000			32,824,000
Valuation allowance		(28,091,000	)		(32,824,000	)
Net deferred tax assets	$	-		$	-

Reconciliation of Income Tax Rate Federal Statutory Rate and Effective Tax Rate

Reconciled below is the difference between the income tax rate computed by applying the U.S. federal statutory rate and the effective tax rate for the years ended December 31, 2018 and 2017.

	Years Ended December 31,
	2018			2017
U. S. federal statutory tax rate		(21.0	)%		(35.0	)%
Forgiveness of indebtedness		-	%		(0.9	)%
Change in valuation allowance		(14.4	)%		(2.4	)%
Adjustment to deferred tax asset		35.4	%		38.8	%
Other		-	%		(0.5	)%
Effective tax rate		0.0	%		0.0	%